uric acid has been researched along with Apnea, Obstructive Sleep in 32 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Previous epidemiological investigations have evaluated the association between gout, serum uric acid levels, and obstructive sleep apnea syndrome (OSAS), but with inconsistent results." | 9.01 | A meta-analysis of the association between gout, serum uric acid level, and obstructive sleep apnea. ( Cheng, C; Liang, M; Min, M; Rizeq, FK; Shi, T; Sun, C; Sun, Y; Zhang, Y, 2019) |
| "Multiple observational studies have reported the close associations of obstructive sleep apnea (OSA) with serum uric acid (SUA) levels and gout." | 8.12 | Assessing the causal associations of obstructive sleep apnea with serum uric acid levels and gout: a bidirectional two-sample Mendelian randomization study. ( Cen, H; Ding, C; He, W; Huang, L; Jin, T; Ni, J; Xie, Y; Zeng, Z; Zhang, L, 2022) |
| "The objective of this observational study was to determine whether there is an association between atrial fibrillation (AF) and uric acid and to identify the risk markers for AF in obstructive sleep apnea (OSA)." | 7.80 | Uric acid levels in obstructive sleep apnea patients with atrial fibrillation. ( Chen, JH; He, YQ; Niu, HY; Wan, YF; Wang, Y; Xu, CQ; Zheng, DH; Zheng, YL, 2014) |
| "Patients with LBS demonstrated similar metabolic features in terms of insulin sensitivity and hyperleptinemia as patients with "simple" truncal obesity." | 7.71 | Insulin resistance, hyperleptinemia, and obstructive sleep apnea in Launois-Bensaude syndrome. ( Ficker, JH; Fuchs, FS; Hahn, EG; Harsch, IA; Konturek, PC; Lohmann, T; Schahin, SP, 2002) |
| "Previous epidemiological investigations have evaluated the association between gout, serum uric acid levels, and obstructive sleep apnea syndrome (OSAS), but with inconsistent results." | 5.01 | A meta-analysis of the association between gout, serum uric acid level, and obstructive sleep apnea. ( Cheng, C; Liang, M; Min, M; Rizeq, FK; Shi, T; Sun, C; Sun, Y; Zhang, Y, 2019) |
| "Multiple observational studies have reported the close associations of obstructive sleep apnea (OSA) with serum uric acid (SUA) levels and gout." | 4.12 | Assessing the causal associations of obstructive sleep apnea with serum uric acid levels and gout: a bidirectional two-sample Mendelian randomization study. ( Cen, H; Ding, C; He, W; Huang, L; Jin, T; Ni, J; Xie, Y; Zeng, Z; Zhang, L, 2022) |
| "The objective of this observational study was to determine whether there is an association between atrial fibrillation (AF) and uric acid and to identify the risk markers for AF in obstructive sleep apnea (OSA)." | 3.80 | Uric acid levels in obstructive sleep apnea patients with atrial fibrillation. ( Chen, JH; He, YQ; Niu, HY; Wan, YF; Wang, Y; Xu, CQ; Zheng, DH; Zheng, YL, 2014) |
| "Patients with LBS demonstrated similar metabolic features in terms of insulin sensitivity and hyperleptinemia as patients with "simple" truncal obesity." | 3.71 | Insulin resistance, hyperleptinemia, and obstructive sleep apnea in Launois-Bensaude syndrome. ( Ficker, JH; Fuchs, FS; Hahn, EG; Harsch, IA; Konturek, PC; Lohmann, T; Schahin, SP, 2002) |
| "Hyperuricemia is associated with the presence and severity of obstructive sleep apnea (OSA)." | 2.78 | Serum urate levels are unchanged with continuous positive airway pressure therapy for obstructive sleep apnea: a randomized controlled trial. ( Prudon, B; Roddy, E; Stradling, JR; West, SD, 2013) |
| "The efficacy of obstructive sleep apnea (OSA) therapy with continuous positive airway pressure (CPAP) on uric acid (UA) yielded conflicting results." | 2.61 | Does Continuous Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnea Improves Uric Acid? A Meta-Analysis. ( Chen, L; Chen, M; Chen, Q; Huang, J; Huang, Y; Li, P; Lin, G; Lin, Q, 2019) |
| "Obstructive sleep apnea syndrome is characterized by periodic apnea/hypopnea, which is often associated with severe hypoxemia." | 2.41 | [Hypoxemia and tissue hypoxia in sleep apnea syndrome]. ( Nishimura, M; Tsujino, I, 2000) |
| "Pulmonary hypertension (PH) is common in obstructive sleep apnea syndrome (OSAS)." | 1.91 | Impact of Pulmonary Hypertension on Renal Functions in Obstructive Sleep Apnea Syndrome. ( Uyar, M, 2023) |
| "The effect of obstructive sleep apnea (OSA) on 24-h urine parameters and resultant kidney stone risk is unknown." | 1.91 | Association between obstructive sleep apnea and 24-h urine chemistry risk factors for urinary stone disease. ( Hsi, RS; Miller, NL; Stone, BV; Sui, W; Tallman, JE, 2023) |
| "Uric acid was negatively correlated with minimum arterial oxygen saturation and mean arterial oxygen saturation, and positively correlated with apnea-hypopnea index, oxygen desaturation index and the duration of time with arterial oxygen saturation < 90% (p < 0." | 1.91 | Clinical outcomes of obstructive sleep apnea in patients with acute coronary syndrome in relation to hyperuricemia status. ( Ai, H; Fan, J; Gong, W; Li, S; Nie, S; Que, B; Wang, G; Wang, X; Yan, Y; Zhang, Z; Zhao, X, 2023) |
| "Uric acid was not correlated with any of the sleep parameters, and no significant differences were detected between the groups." | 1.56 | Uric acid as a marker of severity of obstructive sleep apnoea syndrome in older patients. ( Aydin, Ş; Kahya, Ö; ÖnÜr, ST; Özdemİr, C; SÖkÜcÜ, SN, 2020) |
| "Systemic inflammation is important in obstructive sleep apnea (OSA) pathophysiology and its comorbidity." | 1.46 | Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients without Comorbidities. ( Bouloukaki, I; Kallergis, E; Mauroudi, E; Mermigkis, C; Moniaki, V; Schiza, SE; Tzanakis, N, 2017) |
| "Uric acid was significantly higher in those who had a cardiovascular event even in the mild, moderate and severe OSA groups." | 1.40 | Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome. ( Erden, A; Inonu, H; Johnson, RJ; Kanbay, A; Kanbay, M; McFann, K; Ozturk, MA; Solak, Y; Uslu, E; Yuksel, SA, 2014) |
| "Uric acid levels were correlated with most important risk factors for OSAS, such as AHI, desaturation time and index, minimum oxyhemoglobin saturation (SpO2), blood pressure, cholesterol, BMI, triglycerides and arousal, and with OSAS itself." | 1.39 | Association between uric acid levels and obstructive sleep apnea syndrome in a large epidemiological sample. ( Andersen, ML; Bittencourt, LR; Guindalini, C; Hirotsu, C; Mazzotti, DR; Tufik, S, 2013) |
| "2008 and Mar." | 1.37 | [Correlation between serum uric acid levels and obstructive sleep apnea/hypopnea syndrome in children]. ( Huang, ZY; Liu, DB; Qiu, SY; Shao, JB; Tan, ZY; Wan, GP; Wei, W; Xu, JJ; Zhong, JW, 2011) |
| "EBC was collected in children with obstructive sleep apnea (OSA) and clinically healthy children." | 1.37 | Urates in exhaled breath condensate of children with obstructive sleep apnea. ( Cepelak, I; Dodig, S; Nimac, P; Topic, RZ; Trifunovic, J; Vlasic, V, 2011) |
| "Responses to nocturnal hypoxemia accompanying sleep-disordered breathing (SDB) may vary in different populations." | 1.36 | Uric acid excretion in North American and Southeast European children with obstructive sleep apnea. ( Alexopoulos, E; Bhattacharjee, R; Capdevila, OS; Gourgoulianis, K; Gozal, D; Kaditis, A; Kheirandish-Gozal, L; Kim, J; Papathanasiou, AA; Snow, AB; Varlami, V; Zintzaras, E, 2010) |
| "Twenty three cases diagnosed as OSAHS by polysomnography (PSG) were treated as trial group, 12 cases excluded from OSAHS by PSG were taken as control group,and 15 patients of the trial group were treated by UPPP and were taken as before UPPP therapy group and after UPPP therapy group." | 1.33 | [Significance of the changes of urinary uric acid in OSAHS before and after UPPP]. ( Du, X; Luan, X; Pu, H; Shu, C, 2005) |
| "To investigate the impact of obstructive sleep apnea syndrome (OSAS) on testosterone levels and on the main parameters of the metabolic syndrome in abdominally obese men, 15 male subjects with abdominal obesity phenotype and polysomnographic diagnosis of OSAS (OB-OSAS) and 15 controls matched for age and anthropometric parameters (OB) were investigated." | 1.32 | Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. ( Gambineri, A; Pasquali, R; Pelusi, C, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (21.88) | 29.6817 |
| 2010's | 16 (50.00) | 24.3611 |
| 2020's | 9 (28.13) | 2.80 |
| Authors | Studies |
|---|---|
| Zeng, Z | 1 |
| Jin, T | 1 |
| Ni, J | 1 |
| Huang, L | 1 |
| Xie, Y | 1 |
| He, W | 1 |
| Zhang, L | 2 |
| Ding, C | 1 |
| Cen, H | 1 |
| Uyar, M | 1 |
| Shui, W | 1 |
| Wang, J | 1 |
| Cui, T | 1 |
| Kang, C | 1 |
| Zhang, Z | 2 |
| Qian, RY | 1 |
| Lyu, LC | 1 |
| Wei, TM | 1 |
| Tallman, JE | 1 |
| Stone, BV | 1 |
| Sui, W | 1 |
| Miller, NL | 1 |
| Hsi, RS | 1 |
| Shen, YY | 1 |
| Zhu, J | 1 |
| Shi, Y | 1 |
| Tan, L | 1 |
| Li, TM | 1 |
| Lei, F | 1 |
| Tang, XD | 1 |
| Zhao, X | 1 |
| Li, S | 1 |
| Wang, X | 2 |
| Fan, J | 1 |
| Ai, H | 1 |
| Que, B | 1 |
| Yan, Y | 1 |
| Wang, G | 1 |
| Gong, W | 1 |
| Nie, S | 1 |
| Yang, Z | 1 |
| Lv, T | 1 |
| Lv, X | 1 |
| Wan, F | 1 |
| Zhou, H | 1 |
| Chen, Q | 1 |
| Lin, G | 1 |
| Chen, L | 1 |
| Huang, J | 1 |
| Huang, Y | 1 |
| Li, P | 1 |
| Chen, M | 1 |
| Lin, Q | 1 |
| SÖkÜcÜ, SN | 1 |
| Özdemİr, C | 1 |
| Aydin, Ş | 1 |
| ÖnÜr, ST | 1 |
| Kahya, Ö | 1 |
| Bouloukaki, I | 1 |
| Mermigkis, C | 1 |
| Tzanakis, N | 1 |
| Kallergis, E | 1 |
| Moniaki, V | 1 |
| Mauroudi, E | 1 |
| Schiza, SE | 1 |
| Campos-Rodriguez, F | 1 |
| Reyes-Nuñez, N | 1 |
| Queipo-Corona, C | 1 |
| Sanchez-Armengol, A | 1 |
| Jurado-Gamez, B | 1 |
| Cordero-Guevara, J | 1 |
| Troncoso, MF | 1 |
| Abad-Fernandez, A | 1 |
| Caballero-Rodriguez, J | 1 |
| Martin-Romero, M | 1 |
| Encabo-Motiño, A | 1 |
| Sacristan-Bou, L | 1 |
| Navarro-Esteva, J | 1 |
| Somoza-Gonzalez, M | 1 |
| Masa, JF | 1 |
| Sanchez-Quiroga, MA | 1 |
| Jara-Chinarro, B | 1 |
| Orosa-Bertol, B | 1 |
| Martinez-Garcia, MA | 1 |
| Shi, T | 1 |
| Min, M | 1 |
| Sun, C | 1 |
| Cheng, C | 1 |
| Zhang, Y | 1 |
| Liang, M | 1 |
| Rizeq, FK | 1 |
| Sun, Y | 1 |
| Hirotsu, C | 1 |
| Tufik, S | 1 |
| Guindalini, C | 1 |
| Mazzotti, DR | 1 |
| Bittencourt, LR | 1 |
| Andersen, ML | 1 |
| Prudon, B | 1 |
| Roddy, E | 1 |
| Stradling, JR | 1 |
| West, SD | 1 |
| Wan, YF | 1 |
| Zheng, YL | 1 |
| Niu, HY | 1 |
| Xu, CQ | 1 |
| He, YQ | 1 |
| Wang, Y | 1 |
| Chen, JH | 1 |
| Zheng, DH | 1 |
| Kanbay, A | 1 |
| Inonu, H | 1 |
| Solak, Y | 1 |
| Erden, A | 1 |
| Uslu, E | 1 |
| Yuksel, SA | 1 |
| Ozturk, MA | 1 |
| McFann, K | 1 |
| Johnson, RJ | 1 |
| Kanbay, M | 1 |
| Kosacka, M | 1 |
| Brzecka, A | 1 |
| Piesiak, P | 1 |
| Korzeniewska, A | 1 |
| Jankowska, R | 1 |
| Araz, Ö | 1 |
| Yilmazel Uçar, E | 1 |
| Değırmencı, H | 1 |
| Pulur, D | 1 |
| Acemoğlu, H | 1 |
| Bayram, E | 1 |
| Gündoğdu, F | 1 |
| Akgün, M | 1 |
| Seetho, IW | 1 |
| Parker, RJ | 1 |
| Craig, S | 1 |
| Duffy, N | 1 |
| Hardy, KJ | 1 |
| Wilding, JP | 1 |
| Goodson, NJ | 1 |
| Sunnetcioglu, A | 1 |
| Gunbatar, H | 1 |
| Yıldız, H | 1 |
| Steiropoulos, P | 1 |
| Kotsianidis, I | 1 |
| Nena, E | 1 |
| Tsara, V | 1 |
| Gounari, E | 1 |
| Hatzizisi, O | 1 |
| Kyriazis, G | 1 |
| Christaki, P | 1 |
| Froudarakis, M | 1 |
| Bouros, D | 1 |
| Kaditis, A | 1 |
| Gozal, D | 1 |
| Snow, AB | 1 |
| Kheirandish-Gozal, L | 1 |
| Alexopoulos, E | 1 |
| Varlami, V | 1 |
| Papathanasiou, AA | 1 |
| Capdevila, OS | 1 |
| Bhattacharjee, R | 1 |
| Kim, J | 1 |
| Gourgoulianis, K | 1 |
| Zintzaras, E | 1 |
| Abrams, B | 1 |
| Huang, ZY | 1 |
| Liu, DB | 1 |
| Wan, GP | 1 |
| Zhong, JW | 1 |
| Tan, ZY | 1 |
| Wei, W | 1 |
| Xu, JJ | 1 |
| Shao, JB | 1 |
| Qiu, SY | 1 |
| Vlasic, V | 1 |
| Trifunovic, J | 1 |
| Cepelak, I | 1 |
| Nimac, P | 1 |
| Topic, RZ | 1 |
| Dodig, S | 1 |
| Gambineri, A | 1 |
| Pelusi, C | 1 |
| Pasquali, R | 1 |
| Du, X | 1 |
| Pu, H | 1 |
| Shu, C | 1 |
| Luan, X | 1 |
| Pływaczewski, R | 2 |
| Bednarek, M | 2 |
| Jonczak, L | 2 |
| Górecka, D | 2 |
| Sliwińiski, P | 1 |
| Sliwiński, P | 1 |
| Tsujino, I | 1 |
| Nishimura, M | 1 |
| Harsch, IA | 1 |
| Schahin, SP | 1 |
| Fuchs, FS | 1 |
| Hahn, EG | 1 |
| Lohmann, T | 1 |
| Konturek, PC | 1 |
| Ficker, JH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients[NCT03070769] | 1,053 participants (Actual) | Observational | 2012-06-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for uric acid and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Does Continuous Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnea Improves Uric Acid? A Meta-Analysis.
Topics: Continuous Positive Airway Pressure; Female; Humans; Male; Sleep Apnea, Obstructive; Uric Acid | 2019 |
A meta-analysis of the association between gout, serum uric acid level, and obstructive sleep apnea.
Topics: Adult; Aged; Biomarkers; Body Mass Index; Brazil; Correlation of Data; Disease Susceptibility; Femal | 2019 |
[Hypoxemia and tissue hypoxia in sleep apnea syndrome].
Topics: Adenosine Triphosphate; Biomarkers; Hemoglobins; Humans; Hypoxia; Myoglobin; Sleep Apnea, Obstructiv | 2000 |
2 trials available for uric acid and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Continuous Positive Airway Pressure Treatment Does not Reduce Uric Acid Levels in OSA Women.
Topics: Aged; Continuous Positive Airway Pressure; Female; Humans; Middle Aged; Sleep Apnea, Obstructive; Ur | 2019 |
Serum urate levels are unchanged with continuous positive airway pressure therapy for obstructive sleep apnea: a randomized controlled trial.
Topics: Aged; Continuous Positive Airway Pressure; Diabetes Mellitus, Type 2; Gout; Humans; Hyperuricemia; M | 2013 |
27 other studies available for uric acid and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
Assessing the causal associations of obstructive sleep apnea with serum uric acid levels and gout: a bidirectional two-sample Mendelian randomization study.
Topics: Diabetes Mellitus, Type 2; Genome-Wide Association Study; Gout; Humans; Mendelian Randomization Anal | 2022 |
Impact of Pulmonary Hypertension on Renal Functions in Obstructive Sleep Apnea Syndrome.
Topics: Female; Glomerular Filtration Rate; Humans; Hypertension, Pulmonary; Kidney; Male; Renal Insufficien | 2023 |
Serum uric acid is related to left ventricular geometry and function in patients with obstructive sleep apnea.
Topics: Echocardiography; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Sleep Apnea, Obstructive; | 2023 |
[Research progress on the relationship between obstructive sleep apnea and uric acid].
Topics: Humans; Risk Factors; Sleep Apnea, Obstructive; Uric Acid | 2023 |
Association between obstructive sleep apnea and 24-h urine chemistry risk factors for urinary stone disease.
Topics: Adult; Humans; Kidney Calculi; Male; Retrospective Studies; Risk Factors; Sleep Apnea, Obstructive; | 2023 |
[Clinical Characteristics of Obstructive Sleep Apnea and Comorbid Primary Aldosteronism].
Topics: Aldosterone; Comorbidity; Humans; Hyperaldosteronism; Retrospective Studies; Sleep Apnea, Obstructiv | 2023 |
Clinical outcomes of obstructive sleep apnea in patients with acute coronary syndrome in relation to hyperuricemia status.
Topics: Acute Coronary Syndrome; Humans; Prospective Studies; Risk Factors; Sleep Apnea, Obstructive; Uric A | 2023 |
Association of serum uric acid with all-cause and cardiovascular mortality in obstructive sleep apnea.
Topics: Cardiovascular Diseases; Humans; Nutrition Surveys; Prospective Studies; Risk Factors; Sleep Apnea, | 2023 |
Uric acid as a marker of severity of obstructive sleep apnoea syndrome in older patients.
Topics: Adult; Aged; Body Mass Index; Female; Humans; Male; Polysomnography; Retrospective Studies; Sleep Ap | 2020 |
Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients without Comorbidities.
Topics: Adult; Biomarkers; Blood Sedimentation; C-Reactive Protein; Cross-Sectional Studies; Fibrinogen; Hum | 2017 |
Association between uric acid levels and obstructive sleep apnea syndrome in a large epidemiological sample.
Topics: Adult; Body Mass Index; Brazil; Case-Control Studies; Demography; Female; Humans; Linear Models; Mal | 2013 |
Uric acid levels in obstructive sleep apnea patients with atrial fibrillation.
Topics: Adult; Aged; Atrial Fibrillation; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate A | 2014 |
Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome.
Topics: Cardiovascular Diseases; Cohort Studies; Humans; Hyperuricemia; Risk Factors; Sleep Apnea, Obstructi | 2014 |
Soluble ligand CD40 and uric acid as markers of atheromatosis in patients with obstructive sleep apnea.
Topics: Adult; Atherosclerosis; Biomarkers; Case-Control Studies; CD40 Ligand; Female; Humans; Hypertension; | 2015 |
The correlation of ECHO findings of right cardiac pathologies with BNP, uric acid, and CRP in OSAS.
Topics: Adult; Comorbidity; Echocardiography, Doppler; Female; Heart Diseases; Humans; Male; Middle Aged; Na | 2014 |
Serum urate and obstructive sleep apnoea in severe obesity.
Topics: Adult; Blood Pressure; C-Reactive Protein; Continuous Positive Airway Pressure; Female; Follow-Up St | 2015 |
Red cell distribution width and uric acid in patients with obstructive sleep apnea.
Topics: Adolescent; Adult; Aged; Biomarkers; Cardiovascular Diseases; Erythrocyte Indices; Female; Humans; H | 2018 |
Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome.
Topics: Adult; Continuous Positive Airway Pressure; Female; Follow-Up Studies; Humans; Inflammation Mediator | 2009 |
Uric acid excretion in North American and Southeast European children with obstructive sleep apnea.
Topics: Child; Child, Preschool; Environmental Exposure; Female; Greece; Humans; Hypoxia; Linear Models; Mal | 2010 |
Gout as an early warning of concomitant sleep apnea.
Topics: Gout; Humans; Hypoxia; Risk Factors; Sleep Apnea, Obstructive; Uric Acid | 2010 |
[Correlation between serum uric acid levels and obstructive sleep apnea/hypopnea syndrome in children].
Topics: Case-Control Studies; Child; Child, Preschool; Humans; Sleep Apnea, Obstructive; Uric Acid | 2011 |
Urates in exhaled breath condensate of children with obstructive sleep apnea.
Topics: Biomarkers; Breath Tests; C-Reactive Protein; Child; Child, Preschool; Cross-Sectional Studies; Exha | 2011 |
Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters.
Topics: Adipose Tissue; Adult; Anthropometry; Arteries; Body Weight; Cholesterol, HDL; Gonadal Steroid Hormo | 2003 |
[Significance of the changes of urinary uric acid in OSAHS before and after UPPP].
Topics: Adult; Creatinine; Female; Humans; Intraoperative Period; Male; Middle Aged; Palate; Pharynx; Sleep | 2005 |
[Hyperuricaemia in males with obstructive sleep apnoea (osa)].
Topics: Body Mass Index; Comorbidity; Humans; Hyperuricemia; Male; Metabolic Syndrome; Middle Aged; Obesity; | 2005 |
[Hyperuricaemia in females with obstructive sleep apnoea].
Topics: Aged; Body Mass Index; Comorbidity; Estrogens; Female; Humans; Hypertension, Pulmonary; Hyperuricemi | 2006 |
Insulin resistance, hyperleptinemia, and obstructive sleep apnea in Launois-Bensaude syndrome.
Topics: Adult; Aged; Body Mass Index; Glucose Clamp Technique; Humans; Hyperinsulinism; Insulin Resistance; | 2002 |